Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma
Clinical trial NCT00482248 · COMPLETED
Trial details
- NCT number
- NCT00482248
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2006-06-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.